Patent disputes: Patents re-examined

Article Abstract:

The criticism of the patent system in the U.S. became intensified with the start of the century, which saw the emergence of many proposals for overhauling the system. Debate continues even within legal circles regarding injunctions in infringement cases, and while a group of justices appeared to favor injunctions as the norm in infringement cases, others criticized routine use of injunctions, and commented that patents are being used primarily for obtaining licensing fees rather than producing and selling goods

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Patent Programs, Usage, Patents, Patent/copyright issue

---

Patent disputes: 'Trolls' vacuum up patents, demand fees

Article Abstract:

Moneymaking on a patent through licensing is an old practice, and even big businesses make money by licensing patents they do not use themselves. IBM, the largest patent owner in the U.S. earns more than $1.5 billion in licensing fees each year, but some patent trolls vacuum up big portfolios of patents and then wait until defendants have invested heavily in their products before demanding licensing fees.

Product development, Forecasts, trends, outlooks, Public affairs, Alliances, partnerships, Licensing/Sales Agreements, Patent Owners & Lessors, Lessors of Nonfinancial Intangible Assets (except Copyrighted Works), Patent owners and lessors, Ethics, Venture Analysis, Forecasts and trends, Market trend/market analysis, Ethical aspects, Licensing agreements, Business enterprises, Company licensing agreement, Patent licenses, Patent licensing, Patent licencing

---

Battling HIV/AIDS: does U.S. patent policy delay developing countries' access to affordable, new HIV/AIDS drugs?

Article Abstract:

A debate highlighting contrasting opinions on whether U.S. patent policy is hindering developing countries' easy access to new and affordable HIV/AIDS medicines is presented.

Developing Countries, Health aspects, Analysis, Antiviral agents, Anti-HIV agents

Similar abstracts:

• Abstracts: Should U.S. energy policy focus on developing hydrogen fuel cells?
• Abstracts: RIM faces loss of U.S. market for Black Berry. RIM faces tough challenger in Visto. RIM faces new U.S. fight over patents
• Abstracts: Meridian sells aluminum business. U.S. auto parts giant bids for UAP
• Abstracts: Hoechst bids for rest of Celanese. Quebecor eyes U.S. rivals for takeovers
• Abstracts: Middle East Tensions: New 'peace process'? U.S. policy on Iran: new sanctions. Real ID: State rebellion

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.